Cargando…

Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness

BACKGROUND AND OBJECTIVES: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port robotic-assisted adrenalectomy....

Descripción completa

Detalles Bibliográficos
Autores principales: Arghami, Arman, Dy, Benzon M., Bingener, Juliane, Osborn, John, Richards, Melanie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Laparoendoscopic Surgeons 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376215/
https://www.ncbi.nlm.nih.gov/pubmed/25848182
http://dx.doi.org/10.4293/JSLS.2014.00218
_version_ 1782363706215104512
author Arghami, Arman
Dy, Benzon M.
Bingener, Juliane
Osborn, John
Richards, Melanie L.
author_facet Arghami, Arman
Dy, Benzon M.
Bingener, Juliane
Osborn, John
Richards, Melanie L.
author_sort Arghami, Arman
collection PubMed
description BACKGROUND AND OBJECTIVES: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port robotic-assisted adrenalectomy. METHODS: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. RESULTS: The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P = .58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P = .57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P < .001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P = .23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P = .10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P = .17) did not reach statistical significance. CONCLUSION: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy.
format Online
Article
Text
id pubmed-4376215
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Society of Laparoendoscopic Surgeons
record_format MEDLINE/PubMed
spelling pubmed-43762152015-04-06 Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness Arghami, Arman Dy, Benzon M. Bingener, Juliane Osborn, John Richards, Melanie L. JSLS Scientific Papers BACKGROUND AND OBJECTIVES: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port robotic-assisted adrenalectomy. METHODS: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. RESULTS: The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P = .58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P = .57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P < .001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P = .23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P = .10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P = .17) did not reach statistical significance. CONCLUSION: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy. Society of Laparoendoscopic Surgeons 2015 /pmc/articles/PMC4376215/ /pubmed/25848182 http://dx.doi.org/10.4293/JSLS.2014.00218 Text en © 2015 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/3.0/us/), which permits for noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not altered in any way.
spellingShingle Scientific Papers
Arghami, Arman
Dy, Benzon M.
Bingener, Juliane
Osborn, John
Richards, Melanie L.
Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness
title Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness
title_full Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness
title_fullStr Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness
title_full_unstemmed Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness
title_short Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness
title_sort single-port robotic-assisted adrenalectomy: feasibility, safety, and cost-effectiveness
topic Scientific Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376215/
https://www.ncbi.nlm.nih.gov/pubmed/25848182
http://dx.doi.org/10.4293/JSLS.2014.00218
work_keys_str_mv AT arghamiarman singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness
AT dybenzonm singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness
AT bingenerjuliane singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness
AT osbornjohn singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness
AT richardsmelaniel singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness